Vancomycin versus Linezolid in the Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Meningitis

Abstract

Analysis of the findings in the limited cohorts in our study suggests that linezolid is superior to vancomycin for treating MRSA meningitis, especially in cases in which there is a high MIC (2 mg/L) for vancomycin. A clinical study involving larger cohorts may increase the evidence available in relation to this question.